NVO

XETRA:NOV

Novo Nordisk A/S

Add to Watchlist
  • Stock

65.60

−1.28%

14.52

EUR last updated 11/08 02:03:55

Last Close

51.08

08/08 22:32

Market Cap

628.74B

Beta: 0.15

Volume Today

16.42M

Avg: 66.52K

PE Ratio

306.68

PFCF: 557.06

Dividend Yield

1.14%

Payout:46.98%

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other ch...Show More

    Earnings

    Earnings per Share (Estimate*)

    123452020-09-292021-09-292022-09-302023-06-302024-11-05

    Revenue (Estimate*)

    10B20B30B40B50B60B70B2020-09-292021-09-292022-09-302023-06-302024-11-05

    *Estimate based on analyst consensus